Dosing & Uses
Atopic Dermatitis
Pending FDA approval for moderate-to-severe atopic dermatitis
Next:
Pharmacology
Mechanism of Action
Monoclonal antibody that binds to interleukin-13 (IL-13), thereby inhibiting cytokine-induced responses, including the release of proinflammatory cytokines, chemokines, and IgE
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
